Colin Sandercock

Colin Sandercock

Corporate Officer/Principal chez CUE BIOPHARMA, INC.

Fortune : 14 572 $ au 31/08/2026

69 ans
Commercial Services
Consumer Services
Health Technology

Profil

Colin G.
Sandercock
is Senior Vice President-Intellectual Property at Cue Biopharma, Inc. since 2026, with employment at the firm starting in 2017.
Former positions include Partner at Ashurst Perkins Coie US LLP from 2009 to 2017, Co-Chairman-Life Science Practice Group at Proskauer Rose LLP from 2006 to 2009, Co-Chairman-Intellectual Property Practice Group at Heller Ehrman LLP from 2000 to 2006, and Chairman-Chemical Practice Group at Foley & Lardner LLP from 1990 to 2000.
Education includes graduate degrees from the University of Pennsylvania in 1980 and The Catholic University of America in 1984, and an undergraduate degree from Moravian College in 1978.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
05/05/2026 571 ( 0,01% ) 14 572 $ 31/08/2026

Postes actifs de Colin Sandercock

SociétésPosteDébut
CUE BIOPHARMA, INC. Corporate Officer/Principal 01/06/2026

Anciens postes connus de Colin Sandercock

SociétésPosteFin
Corporate Officer/Principal 01/11/2017
Corporate Officer/Principal 01/07/2009
Corporate Officer/Principal 01/01/2006
Corporate Officer/Principal 01/01/2000
Voir l'expérience en détail de Colin Sandercock

Formation de Colin Sandercock

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

64

Relations au 1er degré

8

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées8

Commercial Services

Commercial Services

Consumer Services

Commercial Services

Commercial Services

Consumer Services

Consumer Services

Health Technology

  1. Bourse
  2. Insiders
  3. Colin Sandercock